Cryosite Limited (ASX: CTE)
Sector: Health Care
Market cap: A$60M (as of 2 Nov 2026)
The Company provides an integrated clinical trial logistics service, biological storage and sample management service, including: the storage of cord blood stem cells for private use.
Data as of 2 Nov 2026.
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 21 Aug 2025 | ANDREW KROGER and other entities | Entry | ?% → 26.7% | Filing ↗ |
| 20 Aug 2024 | ANDREW KROGER and other entities | Entry | ?% → 26.72% | Filing ↗ |
| 25 June 2024 | Laurie Thomas Family Nominees Pty Ltd | Entry | ?% → 8.195% | Filing ↗ |
| 25 June 2024 | ANDREW JOHN KROGER AND OTHER ENTITIES NAMED IN PARAGRAPH 4 | Decrease | 41.070% → 26.720% | Filing ↗ |
| 25 June 2024 | Mark Gregory Kerr and Linda Marie Kerr and other entities named in annexure B | Increase | 14.660% → 18.440% | Filing ↗ |
Director trades — on-market
Latest guidance
| Date | Period | Guidance | Source |
|---|---|---|---|
| 13 July 2026 | FY26 | With the Ferndell Street cool room (2°C to 8°C) expansion completed and our Adderley Street facility build out progressing well, Cryosite's focus for FY2027 is converting this additional capacity into client activity. | Filing ↗ |
Ask about CTE in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has CTE raised money in the last year, and at what discount?
- What was CTE's latest cash position and runway?
Loading CTE…